Elizabeth Leshen

Company: Novartis

Job title: Head Of Safety, Efficiency, Gene Therapy & Rare Disease

Seminars:

Panel Discussion: Investment Strategies for Non-Viral & Viral Gene Therapy: From Seed Financing to Series C 10:00 am

• Overview of the investment requirements and strategies across different stages of gene therapy development • Key factors that make gene therapy projects attractive to different types of investors, from venture capitalists to strategic partnersRead more

day: Conference Day Two pt 1